October 12, 2021

Evaluation of total PD-1 expression using multi-color flow cytometry in Metastatic Non-Small Cell Lung Cancer patients treated with Multi-Neoantigen Vector (ADXS-503) in combination of Pembrolizumab to assess T cell subsets

May 27, 2021

Harnessing Flow Cytometry Data to Keep a Phase 1 Trial on Track

May 27, 2021

A “Basket” Trial and an Accelerated Pathway to Proof-of-Concept

May 27, 2021

Development of an IHC-Based Assay for Detection Of P-Cadherin in Tumor Tissue

Development of an IHC-Based Assay for Detection Of P-Cadherin in Tumor Tissue Clinical Application: Patient Selection for Enrollment Key Words: patient stratification, tumor biopsies, quantitative IHC Background: Personalized medicine is an emerging idea in health care; the ability to determine a patient’s responsiveness to a given treatment in advance, through […]
March 24, 2021

On-Demand Webinar: Harnessing CAR-T Therapy for Hematologic Malignancies and Solid Tumors: Experience from City of Hope

March 24, 2021

On-Demand Webinar: Harnessing CAR-T Therapy for Liquid and Solid Tumours (EUROPE)

March 24, 2021

pKDR/KDR Ratio as Possible Predictor of Response in Phase I/II Study of Erlotinib and Bevacizumab for Recurrent or Metastatic Head and Neck Cancer

March 24, 2021

Phase 1 Trial of a Combination of the VEGFR KinaseInhibitor Cediranib(AZD2171) and Bevacizumab in Advanced Malignancies

March 24, 2021

Prospective Real-time Analysis of P-cadherin Expression to Select Patients into a Phase I Oncology Trial